Recommended content

Congressional report on what cannabis rescheduling does—and doesn’t do (Newsletter: May 7, 2026)

ID medical marijuana ballot sigs; AZ legalization rollback stalls; FL gov candidates on cannabis; Target expands hemp THC drink sales; LA penalties

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.

If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

The Congressional Research Service published a report detailing the scope and limitations of the Trump administration’s marijuana rescheduling move for consumers and businesses, saying it “does not immediately bring the state-legal marijuana industry into compliance with federal law” but “appears to authorize end users to possess marijuana for medical use without a [Controlled Substances Act]-compliant prescription.”

“With respect to the manufacture,

Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment
Source

More news